Patent litigation over generic drugs, which has long been concentrated in Delaware and New Jersey, may spread out to more states across the country as a result of a recent Federal Circuit ruling, potentially making disputes more complicated,
In a Law360 article, IP litigation partner Matt Rizzolo (Washington, D.C.) provide insights on the patent venue statute and the Hatch-Waxman Act.
Matt expects the decision to be appealed further, and that there is a possibility that Congress could get involved to pass a new law.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find our more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.